• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于壳聚糖纳米颗粒的鼻内疫苗对副球孢子菌病的生物分布及佐剂效应

Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis.

作者信息

Santos Júnior Samuel Rodrigues Dos, Barbalho Filipe Vieira, Nosanchuk Joshua D, Amaral Andre Correa, Taborda Carlos Pelleschi

机构信息

Laboratory of Pathogenic Dimorphic Fungi, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508000, Brazil.

Department of Medicine and Department of Microbiology and Immunology-The Bronx, Albert Einstein College of Medicine, New York, NY 10461, USA.

出版信息

J Fungi (Basel). 2023 Feb 12;9(2):245. doi: 10.3390/jof9020245.

DOI:10.3390/jof9020245
PMID:36836359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9964167/
Abstract

Paracoccidioidomycosis (PCM) is a fungal infection caused by the thermodimorphic sp. PCM mainly affects the lungs, but, if it is not contained by the immune response, the disease can spread systemically. An immune response derived predominantly from Th1 and Th17 T cell subsets facilitates the elimination of cells. In the present work, we evaluated the biodistribution of a prototype vaccine based on the immunodominant and protective P10 peptide within chitosan nanoparticles in BALB/c mice infected with strain 18 (Pb18). The generated fluorescent (FITC or Cy5.5) or non-fluorescent chitosan nanoparticles ranged in diameter from 230 to 350 nm, and both displayed a Z potential of +20 mV. Most chitosan nanoparticles were found in the upper airway, with smaller amounts localized in the trachea and lungs. The nanoparticles complexed or associated with the P10 peptide were able to reduce the fungal load, and the use of the chitosan nanoparticles reduced the necessary number of doses to achieve fungal reduction. Both vaccines were able to induce a Th1 and Th17 immune response. These data demonstrates that the chitosan P10 nanoparticles are an excellent candidate vaccine for the treatment of PCM.

摘要

副球孢子菌病(PCM)是一种由双相真菌引起的真菌感染。PCM主要影响肺部,但如果免疫反应无法控制病情,疾病会全身扩散。主要由Th1和Th17 T细胞亚群产生的免疫反应有助于清除细胞。在本研究中,我们评估了一种基于免疫显性和保护性P10肽的原型疫苗在壳聚糖纳米颗粒中的生物分布,该疫苗用于感染18型菌株(Pb18)的BALB/c小鼠。所制备的荧光(FITC或Cy5.5)或非荧光壳聚糖纳米颗粒直径在230至350nm之间,两者的Z电位均为+20mV。大部分壳聚糖纳米颗粒存在于上呼吸道,少量分布于气管和肺部。与P10肽复合或结合的纳米颗粒能够降低真菌载量,并且使用壳聚糖纳米颗粒减少了实现真菌减少所需的剂量数。两种疫苗均能够诱导Th1和Th17免疫反应。这些数据表明,壳聚糖P10纳米颗粒是治疗PCM的优秀候选疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/4e3349e0769d/jof-09-00245-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/e3f28b14651b/jof-09-00245-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/ec861a89bcc3/jof-09-00245-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/67df789ff8c0/jof-09-00245-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/d29bfdd3dce7/jof-09-00245-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/5726c4bc473f/jof-09-00245-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/2c24a8716d46/jof-09-00245-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/f78b3a0fc1b8/jof-09-00245-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/b62d8dbbbae2/jof-09-00245-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/4e3349e0769d/jof-09-00245-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/e3f28b14651b/jof-09-00245-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/ec861a89bcc3/jof-09-00245-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/67df789ff8c0/jof-09-00245-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/d29bfdd3dce7/jof-09-00245-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/5726c4bc473f/jof-09-00245-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/2c24a8716d46/jof-09-00245-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/f78b3a0fc1b8/jof-09-00245-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/b62d8dbbbae2/jof-09-00245-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bf/9964167/4e3349e0769d/jof-09-00245-g009.jpg

相似文献

1
Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis.基于壳聚糖纳米颗粒的鼻内疫苗对副球孢子菌病的生物分布及佐剂效应
J Fungi (Basel). 2023 Feb 12;9(2):245. doi: 10.3390/jof9020245.
2
Intranasal Vaccine Using P10 Peptide Complexed within Chitosan Polymeric Nanoparticles as Experimental Therapy for Paracoccidioidomycosis in Murine Model.使用壳聚糖聚合物纳米颗粒包裹的P10肽的鼻内疫苗作为小鼠模型中副球孢子菌病的实验性治疗方法
J Fungi (Basel). 2020 Sep 2;6(3):160. doi: 10.3390/jof6030160.
3
Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin.基于gp43衍生的P10序列和肠炎沙门氏菌鞭毛蛋白FliC的巴西副球孢子菌疫苗制剂。
Infect Immun. 2009 Apr;77(4):1700-7. doi: 10.1128/IAI.01470-08. Epub 2009 Feb 9.
4
Dendritic Cells Primed with Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis.用肽P10致敏的树突状细胞对患有副球孢子菌病的免疫抑制小鼠具有治疗作用。
Front Microbiol. 2017 Jun 14;8:1057. doi: 10.3389/fmicb.2017.01057. eCollection 2017.
5
Therapeutic DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis.针对实验性球孢子菌病的编码肽 P10 的治疗性 DNA 疫苗。
PLoS Negl Trop Dis. 2012;6(2):e1519. doi: 10.1371/journal.pntd.0001519. Epub 2012 Feb 28.
6
Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis.聚(乳酸-乙醇酸)纳米粒显著提高肽 P10 对小鼠球孢子菌病的免疫保护作用。
Br J Pharmacol. 2010 Mar;159(5):1126-32. doi: 10.1111/j.1476-5381.2009.00617.x. Epub 2010 Feb 5.
7
The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide.佐剂在用P10肽免疫后对副球孢子菌病的治疗性保护中的作用。
Front Microbiol. 2012 May 4;3:154. doi: 10.3389/fmicb.2012.00154. eCollection 2012.
8
Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection.一种CD4 + T细胞表位的重组疫苗通过抑制原发性器官感染促进对巴西副球孢子菌负荷的有效控制。
PLoS Negl Trop Dis. 2017 Sep 22;11(9):e0005927. doi: 10.1371/journal.pntd.0005927. eCollection 2017 Sep.
9
Identification of Potentially Therapeutic Immunogenic Peptides From Species.从 物种中鉴定出潜在治疗性免疫原性肽。
Front Immunol. 2021 May 11;12:670992. doi: 10.3389/fimmu.2021.670992. eCollection 2021.
10
Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis.使用源自巴西副球孢子菌43千道尔顿糖蛋白的肽10致敏的树突状细胞进行预防性和治疗性疫苗接种。
Clin Vaccine Immunol. 2012 Jan;19(1):23-9. doi: 10.1128/CVI.05414-11. Epub 2011 Nov 16.

引用本文的文献

1
Immunomodulatory function of chitosan is dependent on complement receptor 3.壳聚糖的免疫调节功能依赖于补体受体3。
Cell Surf. 2025 May 22;14:100146. doi: 10.1016/j.tcsw.2025.100146. eCollection 2025 Dec.
2
Unraveling the Nano World in Paracoccidioidomycosis: Promising Applications of Nanotechnology in Diagnosis, Treatment, and Vaccines: A Mini Review.揭开副球孢子菌病中的纳米世界:纳米技术在诊断、治疗和疫苗方面的应用前景:一篇综述短文
Curr Microbiol. 2025 Apr 28;82(6):264. doi: 10.1007/s00284-025-04251-9.
3
as an Invertebrate Model for Studying Fungal Infections.

本文引用的文献

1
Biodistribution and targeting potential assessment of mucoadhesive chitosan nanoparticles designed for ulcerative colitis scintigraphy.用于溃疡性结肠炎闪烁扫描的粘膜粘附性壳聚糖纳米颗粒的生物分布及靶向潜力评估
RSC Adv. 2018 Jun 6;8(37):20809-20821. doi: 10.1039/c8ra01898g. eCollection 2018 Jun 5.
2
Mucosal vaccines - fortifying the frontiers.黏膜疫苗——强化前沿。
Nat Rev Immunol. 2022 Apr;22(4):236-250. doi: 10.1038/s41577-021-00583-2. Epub 2021 Jul 26.
3
Paracoccidioidomycosis Protective Immunity.副球孢子菌病的保护性免疫
作为研究真菌感染的无脊椎动物模型。
J Fungi (Basel). 2025 Feb 18;11(2):157. doi: 10.3390/jof11020157.
4
Chitosan Nanoparticles for Intranasal Drug Delivery.用于鼻内给药的壳聚糖纳米颗粒
Pharmaceutics. 2024 May 31;16(6):746. doi: 10.3390/pharmaceutics16060746.
5
Vaccine development for pathogenic fungi: current status and future directions.致病真菌疫苗的研发:现状与未来方向。
Expert Rev Vaccines. 2023 Jan-Dec;22(1):1136-1153. doi: 10.1080/14760584.2023.2279570. Epub 2023 Nov 13.
J Fungi (Basel). 2021 Feb 13;7(2):137. doi: 10.3390/jof7020137.
4
Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections.基于纳米颗粒的治疗和疫苗用于治疗系统性真菌感染。
Front Cell Infect Microbiol. 2020 Sep 3;10:463. doi: 10.3389/fcimb.2020.00463. eCollection 2020.
5
Intranasal Vaccine Using P10 Peptide Complexed within Chitosan Polymeric Nanoparticles as Experimental Therapy for Paracoccidioidomycosis in Murine Model.使用壳聚糖聚合物纳米颗粒包裹的P10肽的鼻内疫苗作为小鼠模型中副球孢子菌病的实验性治疗方法
J Fungi (Basel). 2020 Sep 2;6(3):160. doi: 10.3390/jof6030160.
6
Biological Safety and Biodistribution of Chitosan Nanoparticles.壳聚糖纳米颗粒的生物安全性与生物分布
Nanomaterials (Basel). 2020 Apr 23;10(4):810. doi: 10.3390/nano10040810.
7
Isolation and Long-term Cultivation of Mouse Alveolar Macrophages.小鼠肺泡巨噬细胞的分离与长期培养
Bio Protoc. 2019 Jul 20;9(14). doi: 10.21769/BioProtoc.3302.
8
Highly Efficient Transfection of Primary Macrophages with In Vitro Transcribed mRNA.体外转录mRNA对原代巨噬细胞的高效转染
J Vis Exp. 2019 Nov 9(153). doi: 10.3791/60143.
9
Elicitation of Th1/Th2 related responses in mice by chitosan nanoparticles loaded with Brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19.壳聚糖纳米粒负载布鲁氏菌苹果酸脱氢酶、外膜蛋白 10 和 19 诱导小鼠产生 Th1/Th2 相关应答。
Int J Med Microbiol. 2020 Jan;310(1):151362. doi: 10.1016/j.ijmm.2019.151362. Epub 2019 Oct 18.
10
The NLRP3 inflammasome: molecular activation and regulation to therapeutics.NLRP3 炎性小体:分子激活与治疗调控。
Nat Rev Immunol. 2019 Aug;19(8):477-489. doi: 10.1038/s41577-019-0165-0.